Sente Overview

  • Founded
  • 2007
Founded
  • Status
  • Private
  • Employees
  • 49
Employees
  • Latest Deal Type
  • Debt - PPP
  • Latest Deal Amount
  • $1.16M
Latest Deal Amount
  • Investors
  • 2

Sente General Information

Description

Manufacturer of skincare products designed to deliver novel, science-based skincare products. The company's products offer a formulation of the active ingredients which help in cell renewal, new collagen development, skin hydration and gradually lightening the appearance of pigmented lesions, enabling users to achieve younger-looking and healthier skin.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Personal Products
Other Industries
Pharmaceuticals
Internet Retail
Primary Office
  • 2310 Camino Vida Roble
  • Carlsbad, CA 92009
  • United States
+1 (800) 000-0000

Sente Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Sente Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Debt - PPP 15-Apr-2020 $1.16M 000.00 Completed Generating Revenue
8. Debt - General 27-Sep-2018 000 000.00 Completed Generating Revenue
7. Later Stage VC (Series F) 22-Jun-2018 00.000 000.00 000.00 Completed Generating Revenue
6. Later Stage VC (Series E) 08-Sep-2017 000.00 000.00 000.00 Completed Generating Revenue
5. Later Stage VC (Series D) 07-Jun-2017 00.000 000.00 0000 Completed Generating Revenue
4. Later Stage VC (Series C) 02-Jun-2014 000 00.000 0000 Completed Generating Revenue
3. Later Stage VC (Series B) 14-May-2013 00.00 00.000 000.00 Completed Generating Revenue
2. Early Stage VC (Series A) 15-Apr-2011 $847K $1.55M 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) 31-Jan-2009 $698K $698K 00.00 Completed Generating Revenue
To view Sente’s complete valuation and funding history, request access »

Sente Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series F 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series E 00,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
Series D 0,000,000 00.000000 00 00 00 00 00 0.000
Series C 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series B 3,360,000 $0.001000 8% $0.62 $0.62 1x $0.62 5.06%
Series A 3,090,838 $0.001000 8% $0.5 $0.5 1x $0.5 4.65%
To view Sente’s complete cap table history, request access »

Sente Executive Team (15)

Name Title Board Seat Contact Info
Laurent Combredet Chief Executive Officer
Zubin Meshginpoosh Chief Operating Officer
Kleanthis Xanthopoulos Ph.D Co-Founder & Board Member
Michael Corvigno Senior Director, Sales
Will Ater Senior Vice President of Finance & Administration
You’re viewing 5 of 15 executive team members. Get the full list »

Sente Board Members (10)

Name Representing Role Since
Clement Gingras Self Board Member 000 0000
Clinton Carnell Jr. Self Board Member 000 0000
Faheem Hasnain Self Chairman 000 0000
Kleanthis Xanthopoulos Ph.D Sente Co-Founder & Board Member 000 0000
Magda Marquet Ph.D Self Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Sente Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sente Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
PharmaBio Development PE/Buyout Minority 000 0000 000000 0
Cerus Advisors Growth/Expansion Minority 000 0000 000000 0
To view Sente’s complete investors history, request access »